Neurocrine Biosciences (NBIX) Tops Q1 EPS by 29c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $146.23 -3.69%
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q1 EPS of ($0.01), $0.29 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- CCB Int'l Starts Neurocrine Bio. (NBIX) at Outperform
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
